Skip to main content
Diabetes Spectrum : A Publication of the American Diabetes Association logoLink to Diabetes Spectrum : A Publication of the American Diabetes Association
. 2018 Nov;31(4):367. doi: 10.2337/ds18-er04

Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)

Andrew D Santeusanio, Monica M Bowen
PMCID: PMC6243227  PMID: 30510394

In Table 2 on p. 263 of this article, the authors inadvertently included positive instead of negative percentage changes in A1C for 1-year outcomes. The corrected table is shown below. The online version of this article was updated on 14 September 2018 to reflect this change.

TABLE 2.

Addition of Noninsulin Agent Versus Prandial Insulin

Outcomes at 6 Months Prandial Insulin (n = 28) Noninsulin Agent (n = 34) P
Change in A1C, % –0.53 ± 1.19 –0.84 ± 1.19 0.31
Weight change, kg 1.99 ± 2.45 –2.09 ± 4.22 <0.01
Outcomes at 1 Year Prandial Insulin (n = 23) Noninsulin Agent (n = 25) P
Change in A1C, % −0.67 ± 1.2 −0.86 ± 1.3 0.61
Patients with A1C <7.5%, n (%) 7 (30) 7 (28) 0.85
Documented hypoglycemic episodes, n/patient-year 2.6 1.0 0.01

Data are expressed as mean ± SD unless otherwise noted.


Articles from Diabetes Spectrum : A Publication of the American Diabetes Association are provided here courtesy of American Diabetes Association

RESOURCES